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Oxygen and glucose deprivationInhibitors of histone deacetylases are frequently used against ischemia-induced injury, but the
speciﬁcmechanismsof their action arepoorly understood.Here,we report that following a5–7-hoxy-
gen–glucose deprivation (OGD) acetylation of histone H4 at residue K16 (H4K16Ac) decreases by
40–80% in both PC12 cells and primary neurons. This effect can be reverted by treatment with _tri-
chostatin A, or by supplementation with acetyl-CoA. A decrease in H4K16Ac levels can affect the
expression of mitochondrial uncoupling protein 2 (UCP2), huntingtin-interacting protein 1 (HIP1)
and Notch-pathway genes in a cell-speciﬁc manner. Thus, H4K16 acetylation is important for
responses to ischemia and cell energy stress, and depends on both cytosolic and mitochondrial
acetyl-CoA.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Ischemia is a common patho-physiological condition character-
ized by a lack of blood supply and temporary energy deprivation in
brain or myocardial tissue, and results in stroke and infarction [1–
4]. This is investigated with different in vivo and in vitro models
[5–7]. The popular in vitro model of cerebral ischemia is ‘‘oxygen
and glucose deprivation’’ (OGD), which impacts the function of
cells in white and gray matter in the brain [1,8]. Sustained ische-
mia is generally damaging to cells; however, pre-conditioning with
short pulses of hypoxia followed by re-perfusion with oxygen-
saturated nutrient-rich media has been shown to improve cell
survival during subsequent stroke conditions [8,9]. Cell energy
stress and ischemia–reperfusion processes, studied at the molecu-
lar level in various models and cell types (neurons, astrocytes,
endothelial cells), also revealed major roles of hypoxia-inducible
factors in ischemic tolerance [1,10–13].Epigenetic factors represent another mode of regulation of
ischemic tolerance [4,14–16]. Thus, hypoxic and anoxic conditions
affect histone methylation, while histone deacetylase inhibitors
(HDACi) such as valproic acid or trichostain A show neuroprotec-
tive effects during ischemia [17,18]. A number of chromatin-
remodeling complexes, such as SWI/SNF, are involved in cellular
responses to ischemia, with the hypoxia-inducible factor (HIF)
pathway being one of the most important and well studied [19–
21]. Availability of metabolic substrates is also important: revers-
ible acetylation of histones and other proteins depends on the
levels of NAD+ and acetyl-CoA [22,23].
The cellular acetyl-CoA pool is distributed between the cytosol
and mitochondria. Cytosolic acetyl-CoA drives acetylation of
numerous cytosolic and nuclear proteins, while the mitochondrial
pool is essential for the function of the electron transport chain [1].
However, recently it was shown that the mitochondrial pool of
acetyl-CoA can also contribute (up to 50%) to the acetylation of
nuclear histones [24,25]. This suggests that under ischemia, when
the pyruvate dehydrogenase complex is inhibited, mitochondria
can act as cellular stress ‘‘sensors’’ epigenetically regulating gene
expression via histone acetylation.
Among the multiple sites of histone acetylation, the K16 residue
in histone H4 (H4K16Ac) is considered to be one of the versatile
epigenetic marks. It regulates chromatin remodeling and global
activation of gene expression [26], and is often coordinated with
histone H3K4 mono-, di- and trimethylation, and cell cycle pro-
gression [27,28]. Abnormal levels of H4K16Ac lead to defects in
R.I. Dmitriev, D.B. Papkovsky / FEBS Letters 589 (2015) 138–144 139DNA repair, RNA polymerase II-mediated transcription, cell cycle
arrest, altered autophagy and embryonic lethality [29–33]. In
mammals this modiﬁcation is regulated by histone acetyltransfer-
ases KAT8 (MYST1, MOF) [29], KAT5 (TIP60) [34]and KAT2A
(GCN5) [35], and by histone deacetylases such as Sirt1 and HDAC1
[36,37]. These members of distinct multi-protein nuclear com-
plexes [27,37,38] are often cross-regulated [39] and can reversibly
acetylate many important proteins including p53, PGC-1a and oth-
ers [40,41].
Here, we hypothesized that sustained OGD affects H4K16Ac
which in turn contributes to ischemic tolerance, and studied this
with two types of neural cells: PC12 rat pheochromocytoma cells
and mixed culture of primary neurons. We found that H4K16Ac
was markedly reduced over 6 h of OGD, and almost fully restored
by subsequent re-perfusion in PC12 cells. We studied the mecha-
nism of such decrease and found that it is due to the function of
histone deacetylases. Ischemia-dependent decrease of H4K16Ac
affects gene expression in a cell-speciﬁc manner, and this can be
exploited in development of speciﬁc therapies for stroke. Prelimin-
ary data from this work were reported in [42].
2. Methods
2.1. Materials
CellTiter-Glo reagent, CellTox Green viability assay kit, ImProm-
II reverse transcriptase, PCR master mix, ribonuclease inhibitor and
SV Total RNA Isolation system were from Promega (MyBio,
Kilkenny, Ireland). Nucleo-spin II RNA extraction kit was from
Macherey–Nagel (Fisher Scientiﬁc, Dublin, Ireland). Sodium dichlo-
roacetate (DCA) was from Tocris Bioscience (Abingdon, UK). Rabbit
anti-histone H4 (04-858), H4K16Ac (07-329) antibodies were from
Millipore (Cork, Ireland). Goat anti-MOF, TIP60 and VDAC antibod-
ies were from Santa Cruz Biotechnology (Heidelberg, Germany).
Mouse monoclonal anti-GCN5/KAT2A, anti-Sirt1, rabbit polyclonal
anti-KDM1/LSD1, anti-histone H3 (tri-methyl K4) and anti-
pyruvate dehydrogenase kinase 1 antibodies were from Abcam
(Cambridge, UK). Anti-acetylated-lysine mouse mAb (Ac-K-103)
antibody was from Cell Signaling Technology (Dublin, Ireland),
anti-PGC-1a rabbit antibody was from Calbiochem-Millipore
(Cork, Ireland). Anti-HIF-2a goat antibody (AF2886) was from
R&D systems (Minneapolis, USA). Secondary IRdye 800CW anti-
bodies were from LI-COR Biosciences (UK). SafeView DNA stain
was from NBS Biologicals (UK). Pre-cast polyacrylamide gels, and
electrophoresis running and transfer buffers were from Genscript
(Piscataway, NJ, USA). ECL Plus and Prime western blotting
reagents were from GE Healthcare Life Sciences (Cork, Ireland).
Anti-a-tubulin and acetyl-a-tubulin antibodies, horseradish per-
oxidase-conjugated secondary anti-rabbit (RG-96), goat/sheep
(GT-34) and mouse (A9917) antibodies, (+/)-carnitine, DL-acetyl-
carnitine, protease inhibitor cocktail, sodium butyrate, valproic
acid, trichostatin A and all the other reagents were from Sigma–
Aldrich (Dublin, Ireland). Oligonucleotide primers were synthe-
sized by Sigma–Aldrich (Dublin, Ireland).
2.2. Cell culture
PC12 rat pheochromocytoma cells were cultured in suspension
in RPMI1640 medium supplemented with 10% horse serum and 5%
fetal bovine serum as described before [43]. For oxygen and glu-
cose deprivation (OGD), cells were seeded in 25 cm2 ﬂasks (low
attachment surface, Corning) at 2–2.5 ⁄ 106/ﬂask. Next day they
were collected by centrifugation (200g, 5 min), quickly
resuspended in OGD medium (phenol red- and glucose-
free DMEM, supplemented with 1 mM sodium pyruvate, 2 mMglutamine, 10 mM HEPES-Na, pH 7.2) in 25 cm2 ﬂasks, placed at
0% O2 (veriﬁed with ‘‘Optech Platinum’’ –O2 sensor, Mocon, USA)
[44] in a modular incubator chamber (Billups-Rothenberg, Inc,
USA) for 0–9 h, followed by histone, total protein or RNA extraction.
For assessment of cell viability by measuring total ATP, cells
were seeded onto collagen IV-coated StripWell plates (Corning,
USA) at a density of 150000/well, allowed to attach (1.5 h),
exposed to OGD and re-perfusion, and then lysed using CellTiter-
Glo reagent as per manufacturer’s instructions and measured on
a microplate reader (total luminescence). For assessment of cell
viability with the CellTox Green kit, cells were seeded and treated
similarly, and then analyzed using an end-point method as per
manufacturer’s instructions on a ﬂuorescence plate reader (485/
535 nm ﬁlters, top reading). The control (untreated) cells were
used as 100% viable and lysed as 0%.
Results of cell viability assays were normalized by extracting
total protein with PEB buffer (50 mM HEPES-Na, pH 7.4, 150 mM
NaCl, 1 mM EDTA, 1% Igepal CA630, protease inhibitor cocktail
Sigma P2714) and analysis with a BCA Protein assay kit (Pierce,
Thermo Fisher, Ireland). Control experiments were performed in
medium supplemented with D(+)-glucose (10 mM), serum or
drugs, as described in the ‘‘Results’’ section. For re-perfusion, sam-
ples exposed to OGD were pelleted, resuspended in complete
growth media, incubated at ambient O2 for further 18 h and then
analyzed.
The mixed culture of embryonic rat E18 cortical neurons was
obtained as described previously [45]. All the procedures with
animals were performed under a license issued by the Irish
Government Department of Health and Children (Ireland) and in
accordance with the Directive 2010/63/EU adopted by the Euro-
pean Parliament and the Council of the European Union. Brieﬂy,
cells were seeded on poly-D-lysine-coated 25 cm2 ﬂasks (10 ⁄ 106
cells/ﬂask) in DMEM-F12 Ham medium supplemented with 2%
B27, 1% fetal bovine serum and 1% penicillin–streptomycin,
cultured for 7 days at ambient O2, and then exposed to OGD as
above in media supplemented with 2% B27.
2.3. Protein extraction and Western blotting
Histones were extracted as described before [46]. Extracts were
cleared by centrifugation (600g, 10 min) and total proteins were
quantiﬁed by the Bradford method. Samples normalized for total
protein were mixed with 5 Sample Laemmli Buffer, incubated
for 10 min at room temperature, and analyzed by western blotting
as described before [43], using either chemiluminescent (ECL Plus)
or ﬂuorescently labeled (IRdye 800CW) secondary antibodies and
detection.
For total protein extraction, 5 ⁄ 106 cells exposed to OGD, were
supplemented with 5 mM sodium butyrate (BA), washed in ice-
cold PBS supplemented with 5 mM sodium butyrate (BA), lysed
in 500 ll of PEB buffer (30 min, 4 C), pelleted (12000 g, 15 min).
Soluble extracts were quantiﬁed by BCA protein assay kit.
2.4. RNA extraction and RT-PCR
4–5 ⁄ 106 cells exposed to OGD were collected and washed
in PBS, supplemented with 5 mM BA as above, washed in 300 ll
of RNA later reagent and stored at 18 C prior the extraction.
Total RNA was isolated using SV Total RNA isolation system or
Nucleo-Spin II RNA extraction kit, accordingly to manufacturer’s
instructions. 1–2 lg of total RNA were annealed with 500 ng
oligo-(dT)15 (70 C for 5 min, 4 C for 5 min), reverse transcribed
using ImProm-II reverse transcriptase, and analyzed by PCR
(25–30 cycles). Oligonucleotide primer sequences are provided in
Supplementary Table 1.
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Statistical analysis was performed using the results of at least 3
independent experiments. Plate reader data (ATP) represent aver-
age values produced from 3 (N) independent experiments with 4
replicates, with standard deviation shown as error bars. Western
blotting and RT-PCR data were evaluated for statistical difference
using independent t-test with conﬁdence levels P = 0.5, 0.05 or
0.005 (indicated with asterisks) accepted as signiﬁcant. Band
intensities quantiﬁed in with Li-Cor Odyssey software or ImageJ
(NCBI), were normalized to control (1) and total H4 (H4K16Ac
samples) and then averaged between 3 independent experiments,
with standard deviation shown as error bars. RT-PCR experiments
were performed in duplicates, with band intensities averaged, nor-
malized to control (100%) and GAPDH signals, and compared
between 3 independent experiments.
3. Results and discussion
3.1. In vitro ischemia decreases H4K16Ac
Typical in vitro ischemia experiments include exposure of cells
to OGD for 0.5–15 h [8,47–49]. Previously it was shown that 6 h
OGD has minor effects on viability and can be used for ischemic
preconditioning of PC12 cells, while development of ischemic tol-
erance occurs after 15–24 h of re-perfusion [8]. Analysis of proteins
extracted from PC12 cells after 5 h OGD and following 18 h re-per-
fusion revealed changes in H4K16Ac and enzymes involved in(A)
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of a-tubulin acetylation was noticed during OGD but was restored
upon re-perfusion. This can be due to increased cell adhesion dur-
ing OGD [50]. The total mitochondrial mass assessed by porin/
VDAC (voltage-dependent anion channel) protein levels remained
unchanged. We however noticed slight modulation of levels of
the main histone acetyltransferases (KAT8, KAT5) and Sirt1,
involved in regulation of H4K16Ac. Remarkably, we observed that
H4K16Ac decreased upon OGD and then was restored upon re-per-
fusion (Fig. 1A).
We investigated the time dependence of the decrease in
H4K16Ac upon OGD. We found that it was time-dependent, reach-
ing a minimum (20–30% from initial) after 5–7 h of exposure
(Fig. 1B). Serum withdrawal had a moderate effect on H4K16Ac;
however, the decrease was abolished by inhibition of histone
deacetylases with trichostatin A (TSA) (Fig. 1B). Both 1 h and 5 h
exposure of PC12 cells to OGD combined with re-perfusion led to
restoration of H4K16Ac levels (Fig. S1). Considering the coordi-
nated action of H4K16Ac and H3K4 di- or tri-methylation [27],
we looked at these two modiﬁcations, but detected no H3K4Me3
(not shown). This can be explained by cell speciﬁcity of the histone
methylation.
To see if the effects are common to other cell types, we pro-
duced a mixed culture of rat primary embryonic cortical neurons
and glial cells, and treated them similarly. Again we found a
decrease in H4K16Ac by 50% after 5 h OGD (Fig. 1C). The levels of
H4K16Ac were restored by treatment with TSA during OGD, but
remained unchanged (decreased) upon re-perfusion. This can beH4K16Ac
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cells in mixed primary culture.
Thus, relatively short (3–7 h) OGD induces rapid and signiﬁcant
(up to ﬁvefold) deacetylation of H4K16Ac in two different types of
neural cells. The restoration of H4K16Ac in PC12 cells can indicate
involvement of this modiﬁcation in ischemic tolerance.
3.2. Decrease of H4K16Ac during OGD is caused mainly by histone
deacetylation
Since one of the main outcomes of ischemia is cell death [1], we
assessed cell viability by measurement of total ATP and membrane
integrity (CellTox Green assay) (Figs. 2A and S2). Interestingly, with
the membrane integrity dye we observed an apparent increase of
viability (Fig. S2) during OGD, which can be explained by alteration
of PC12 cells adhesion properties upon OGD and lower membrane
permeability for ﬂuorescent dye [8]. Still, 5 h OGD with following
re-perfusion led to signiﬁcant cell death (Fig. S2). In contrast, mea-
surements of total cellular ATP showed a decrease during 5 h OGD,
but with restoration to almost 100% upon re-perfusion (Fig. 2A).
Thus, if the energy stress experienced by PC12 cells leads to their
massive death, they still are able to recover their ATP after re-per-
fusion. These data are in agreement with those previously reported
[8], and suggest that our model can be used for studying ischemic
tolerance even though there is massive ischemic injury.(A) (B
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tion (GD) alone the decrease was not statistically signiﬁcant
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tone deacetylases in resting cells.
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effect. We found that both acetylcarnitine (ALCAR) and carnitine
improved H4K16Ac during OGD, but not signiﬁcantly (Fig. 2C).
Thus, our results conﬁrmed that H4K16Ac decreases upon OGD
due to sustained activity of histone deacetylases, and this can be
reversed and restored by TSA treatment. HATs performing acetyla-
tion of H4K16 must be still active under ischemia, and OGD-
induced decrease of mitochondrial ACA may be responsible for
the decrease in total H4K16Ac. Both Sirt1 and HDAC1 were shown
to be responsible for H4K16Ac deacetylation [36,37]; however TSA,
which mainly inhibits HDAC1, was able to fully restore H4K16Ac
levels in our experiments. This points to HDAC1 as the main his-
tone deacetylase responsible for H4K16Ac status under ischemia.
On the other hand, OGD can affect NAD+ and (in)activate Sirt1, also
regulating levels of H4K16Ac.
Hypoxia-inducible factors (HIFs) provide another level of regu-
lation of H4K16Ac [19,20]. Stabilization of HIF-1/2a proteins upon
OGD can regulate chromatin de-compaction and H4K16Ac status.
H4K16Ac itself can also regulate accessibility of hypoxia-respon-
sive genes to HIF-1/2a binding. We previously showed that in
PC12 cells the dominating HIF-2a is strongly stabilized by oxygen
depletion, but only if glucose is present in the media [43]. Here we
also observed no HIF-2a stabilization after 5 h OGD, and that
cobalt chloride (a mimic of hypoxia stabilizing HIF-2a) had no
effect on H4K16Ac (not shown). We can therefore conclude that
HIF-2a is not directly involved in regulation of H4K16Ac during
OGD. However, TSA-treated samples showed a noticeable stabiliza-
tion of HIF-2a levels after OGD (Fig. 2D). Hence, H4K16Ac, direct
acetylation, or other acetylated proteins can have an inﬂuence on
HIF-2a stabilization.
3.3. Decreased H4K16Ac has cell-speciﬁc effects on gene expression
H4K16Ac is associated with global chromatin remodeling
[26,27] and general (non-speciﬁc) activation/repression of chroma-
tin and gene expression [52]. However, a number of speciﬁc genes
expressed according to H4K16Ac status were also reported, includ-
ing the uncoupling protein UCP2, calreticulin, HOXA9, and hun-
tingtin-interacting protein 1 (HIP1) [30], as well as HES1, HEY2
and Notch1 involved in neurogenesis [36]. Activity of the main
HATs involved acetylation of H4K16Ac, namely KAT8 and KAT5,
also leads to the acetylation of p53 (K120) and activation of pro-
apoptotic genes BAX and OBSL1/PUMA [41].
We therefore tested if the OGD-induced decrease of H4K16Ac
(or effects on other acetylated proteins) regulates the function of
these genes (Fig. 3). Since no signiﬁcant differences in gene expres-
sion occurred immediately after OGD (not shown), we focused on
samples of PC12 cells exposed to 5 h OGD and 18 h re-perfusion.
We detected decreases in UCP2, calreticulin and HIP1, which can
be associated with the overall decrease in H4K16Ac [30]. On the
other hand, pro-apoptotic BAX and OBSL1 were upregulated, sug-
gesting induction of apoptosis in cells (Fig. 3A). This agrees with
the general paradigm that OGD promotes cell death [1] and sug-
gests that KAT8-catalyzed p53 acetylation [41] is not involved in
activation of these genes in PC12 cells.
Sirt1 and HDAC1-mediated deacetylation of H4K16Ac affects
the function of the Notch pathway, which is important for embry-
onic and stem cell development, and for cell recovery under ische-
mic conditions [36]. Expression of Notch1, 2 and 4 isoforms and
associated HES1 and HEY2 genes was seen in PC12 cells, but
HOXA9 was undetectable (Fig. S3). Expression of HES1 and Notch4
was affected by OGD, being unaffected by TSA treatment. Thus, we
can conclude that H4K16Ac does not regulate these genes during
5 h OGD.
With primary cortical neuron cultures we observed rather
different effects of OGD (Fig. 3B): UCP2 was upregulated andcalreticulin expression did not change, while HIP1 behaved simi-
larly to as in PC12 cells. UCP2 and HIP1 responses were altered
by TSA, thus suggesting that their expression can be correlated
with H4K16Ac. Similarly, BAX and OBSL1, which are regulated
through KAT8-p53 acetylation, demonstrated ‘inverse’ responses.
Regulation of OBSL1 expression was similar to that previously
reported [41]. In primary neurons all Notch isoforms altered their
expression levels upon blocking of histone deacetylases and OGD
treatment, but the patterns were different from those observed
in PC12 cells (Figs. 3C and S3B). We also detected HOXA9 in sample
exposed to OGD and TSA, but not under other conditions used
(Fig. S3). This gene is likely to be regulated by H4K16Ac, but it is
normally strongly suppressed by the function of histone deacety-
lases. The observed upregulation could indicate that OGD/TSA
mimic some developmental pathways in stem cells during post-
ischemic neurogenesis [36].
4. Conclusions
Using two models of neural cells we demonstrated signiﬁcant
and reversible changes in H4K16Ac (up to ﬁvefold) during
in vitro ischemia and OGD. These data are in agreement with
recently published results by Yildirim and co-workers [53] which
studied effect of OGD on overall H4 and H3 acetylation. Seemingly,
H4K16Ac levels are altered by coordinated action of HATs (KAT8,
KAT5 or KAT2A) and histone deacetylases (HDAC1 and/or Sirt1),
R.I. Dmitriev, D.B. Papkovsky / FEBS Letters 589 (2015) 138–144 143and can be restored by re-perfusion or treatment with trichostatin
A. Gene expression data provide evidence suggesting that H4K16Ac
regulates transcription of certain genes involved in the mitochon-
drial function (UCP2 [54,55]), neurodegenerative disorders (HIP1
[56]) and developmental programs (neurogenesis through Notch
pathway [36,57]). Previously, it was shown that Sirt1 can directly
regulate UCP2 in pancreatic cells during calorie restriction, by
binding to its promoter [54]. Our results suggest another regula-
tion pathway in neural cells – through decreased H4K16Ac. Recent
data also support the paradigm of activation of neurogenesis in
surviving post-ischemic cells, through Notch1 and related path-
ways [57–60]. In accordance with this, we also observed slight
upregulation of PCNA after re-perfusion (not shown), suggesting
increased proliferation.
The two tested cell models showed different responses of Notch
pathway components to OGD. These cell-speciﬁc effects on gene
expression can be explained by the different developmental state
of these cell types: transformed cancer PC12 cells and primary
neurons and glia from embryonic brain. These data also point to
the possibility of cell-speciﬁc response of diverse neurons, glia
(embryonic or adult) to decrease of histone H4K16 acetylation
and other histone marks. Hence, reversible alterations in
H4K16Ac during ischemia–reperfusion may play important roles
in cell adaptation, mitochondrial function (through UCP2) and neu-
rogenesis pathways, thus demonstrating an important role of
reversible protein acetylation during physiological and pathologi-
cal conditions.
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